1 / 14

Advances in Genetics and Molecular Medicine: Impact on Deafness and NTID

Advances in Genetics and Molecular Medicine: Impact on Deafness and NTID. Research Department Brown Bag Series February 15, 2010. Human Gene Mapping: Why so Difficult?. Humans are lousy a species for classical genetic research. Almost nothing was known about the genetic map.

rasha
Download Presentation

Advances in Genetics and Molecular Medicine: Impact on Deafness and NTID

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Advances in Genetics and Molecular Medicine: Impact on Deafness and NTID Research Department Brown Bag Series February 15, 2010

  2. Human Gene Mapping: Why so Difficult? • Humans are lousy a species for classical genetic research. • Almost nothing was known about the genetic map. • Back lash from the eugenics movement. • Magnitude of the Project. • Lack of appropriate tools and technology

  3. Mapping Analogy Geography/Genome

  4. Basic Research Discoveries • In vitro method of mapping human genes. • Discovery of Restriction Enzymes and methods for cloning DNA. • Polymerase Chain Reaction (PCR). • Restriction Fragment Length Polymorphisms. • Automated DNA Sequencing Methods. • Funding.

  5. Goals of the Human Genome Project • identify all the approximately 20,000-25,000 genes in human DNA, • determine the sequences of the 3 billion chemical base pairs that make up human DNA, • store this information in databases, • improve tools for data analysis, • transfer related technologies to the private sector, and • address the ethical, legal, and social issues (ELSI) that may arise from the project.

  6. Molecular Medicine: Gene Testing Common Uses: Carrier Screening Preimplantation Prenatal Diagnosis Newborn Screening Presymptomatic – Adult Onset Presymptomatic – Risk Assessment Confirmation of Diagnosis Forensic/Identity testing

  7. Molecular Medicine: Gene Therapy Uses: Replacing an abnormal gene Insertion of a normal gene Repair an abnormal gene Altering gene regulation

  8. Molecular Medicine: Pharmacogenetics Uses: • More effective medicines • Safer drugs • More accurate drug dosages • Better vaccines • Drug discoveries • Reduction in health care costs.

  9. Ethical, Legal, Social Issues • Privacy and confidentiality of Genetic Information. • Fairness in the use of genetic information, e.g. Insurers, employers, courts • Reproductive issues, e.g. effective informed consent, use of genetic information in reproductive decisions. • Uncertainty with gene tests for susceptibility to complex conditions. • Fairness in access to advanced genomic technology. • Philosophical and conceptual implications for human responsibility – free will vs. determinism; Concepts of health and disease. • Commercialization of products, e.g. patents. • http://www.genome.gov/27535101

  10. Genetic Information Nondisclosure Act (GINA) Fifteen Years in the Making Passed in May, 2008; in place October, 2009. • May not Use Genetic Information for Risk Selection or Risk Classification Purposes • May not Require Genetic Tests/Genetic Information • May not Establish Rules for Eligibility based on Genetic Information • May not Disclose Information Without Informed Consent

  11. Genetics and Deafness Estimates: 250,000,000 people world-wide have some level of hearing loss; 50% of individuals with hearing loss have a genetic basis. Nonsyndromic hearing loss (70%) hearing Autosomal recessive Autosomal dominant X-linked Mitochondrial Syndromic hearing loss (30%) Recessive Dominant

  12. Examples

  13. Eugenic Movement in USA

  14. Shades of Eugenics in USA

More Related